Clinical trial
A Clinical Study of Intravenous Immunoglobulin
NCT00468273 · FFF Enterprises, Industry · Completed
Key facts
| NCT number | NCT00468273 |
|---|---|
| Title | A Clinical Study of Intravenous Immunoglobulin |
| Official title | A Clinical Study of Immune Globulin Intravenous (Human) Omr-IgG-am IGIV in Subjects With Primary Immune Deficiency Diseases |
| Acronym | IGIV |
| Lead sponsor | FFF Enterprises, Industry |
| Collaborators | OMRIX Biopharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Immunologic Deficiency Syndromes |
| Intervention type | Drug |
| Interventions | Immune Globulin Intravenous (Human) Omr-IgG-am IGIV |
| Enrollment | 57 |
| Start date | Nov 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | May 2, 2007 |
| Last update posted | Aug 11, 2014 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: